Orit Lidor - Clal Biotechnology Insider

CBI -- Israel Stock  

ILS 286.50  6.70  2.29%

VP and General Counsel

We currently do not have informatin regarding Orit Lidor. This executive tanure with Clal Biotechnology Industries Ltd is not currenlty determined.
Age: 35  VP Since 2011      
972 3 612 1616  http://www.cbi.co.il

Management Efficiency

The company has return on total asset (ROA) of (4.84) % which means that it has lost $4.84 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (2.88) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 71.88 M in total debt with debt to equity ratio (D/E) of 8.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Clal Biotechnology Industries Ltd has Current Ratio of 5.82 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 4 records

VP Since

Ofir MoradMizrahi Tefahot Bank Ltd
Shimon AbudrahamAmot Investment Ltd
Sandra AdzicMazor Robotics Ltd
Avi HalfonAmot Investment Ltd

Entity Summary

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. Clal Biotechnology is traded on Tel Aviv Stock Exchange in Israel.Clal Biotechnology Industries Ltd (CBI) is traded on Tel Aviv Stock Exchange in Israel. It is located in Azrieli Center and employs 14 people.

Clal Biotechnology I Leadership Team

Ofer Goldberg, VP
Sigalia Heifetz, Director
Shmuel Rubinstein, Director
Tomer Babai, Director
Dafna Gruber, Director
Aharon Schwartz, Director
Gavriel Barabash, Director, Ph.D
Isaac Kohlberg, Director, MBA
Nofar Malovani, Director
Assaf Segal, CFO, MBA
Ofer Gonen, President
Avraham Fischer, Chairman
Yuval Yanai, Director
Julian Adams, President
Orit Lidor, VP

Stock Performance Indicators

Current Sentiment - CBI

Clal Biotechnology I Investor Sentiment
Most of Macroaxis users are currently bullish on Clal Biotechnology Industries Ltd. What is your opinion about investing in Clal Biotechnology Industries Ltd? Are you bullish or bearish?
98% Bullish
2% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Public Service and Dominion Energy. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.